🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma

mBio(2021)10.1128/mbio.00765-21Source: DataRank Database

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma is a research paper published in mBio (2021). On theSindex it has a DataRank of 0. It has been cited 83 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access83 citations

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (29 grants)Impact (FWCI 4.50)OA: goldTopics (88)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Andrew R. Crowley ORCID,Savannah E. Butler,Shiwei Xu ORCID,Joshua A. Weiner ORCID,Evan M. Bloch ORCID

Live enrichment

PubMed:33879585 PMC:PMC8092262 OpenAlex:https://openalex.org/W3153222280

HHS | National Institutes of Health

Grant: R01AI120938

HHS | National Institutes of Health

Grant: R01AI120938S1

HHS | National Institutes of Health

Grant: R01AI128779

HHS | National Institutes of Health

Grant: HHSN272201400007C

HHS | National Institutes of Health

Grant: T32AI102623

HHS | National Institutes of Health

Grant: K23HL151826

HHS | National Institutes of Health

Grant: P30 CA 023108-41

HHS | National Institutes of Health

Grant: P20-GM113132

HHS | National Institutes of Health

Grant: AI052733

HHS | National Institutes of Health

Grant: AI15207

HHS | National Institutes of Health

Grant: HL059842

HHS | National Institutes of Health

Grant: 2T32AI007363

U.S. Department of Defense

Grant: W911QY2090012

NIAID NIH HHS

Grant: R01 AI152078

NIGMS NIH HHS

Grant: P20 GM113132

NIAID NIH HHS

Grant: T32 AI007363

NIAID NIH HHS

Grant: HHSN272201400008C

NIAID NIH HHS

Grant: R01 AI052733

NHLBI NIH HHS

Grant: R01 HL059842

NIAID NIH HHS

Grant: DP1 AI152073

NCI NIH HHS

Grant: 2 P30 CA 023108-41

National Institutes of Health

Grant: 3P30CA023108-41S8

Cancer Center Support Grant

National Institutes of Health

Grant: 1K23HL151826-01

The Malaria Transfusion Risk (MATRix) Study

National Institutes of Health

Grant: 5T32AI007363-23

Immunobiology of Myeloid and Lymphoid Cells

National Institutes of Health

Grant: 1R01AI128779-01

Penile Microbiome, Inflammation and HIV Susceptibility During Sexual Debut and Maturation Among Male Adolescents

National Institutes of Health

Grant: 5R01HL059842-22

Synergy of Host Defense Mechanisms in the Lung

National Institutes of Health

Grant: 5R01AI120938-05

Unlocking the Potential of HIV-Infected Deceased Donors for Organ Transplantation

National Institutes of Health

Grant: 3P20GM113132-05S1

Pellegrini Administrative Supplements for Helium Recovery Systems

National Institutes of Health

Grant: 2T32AI102623-11

Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program

FWCI

4.50

Citation Percentile

1.0%

Influential Citations

2

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00765-21

GOLDhttps://doi.org/10.1128/mbio.00765-21

publisherhttps://doi.org/10.1128/mbio.00765-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/mBio.00765-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33879585

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingMedicine0301 basic medicine03 medical and health sciencesAdultAgedAntibodies, NeutralizingAntibodies, ViralAntibody SpecificityAntibody-Dependent Cell CytotoxicityAntigens, ViralBiophysical PhenomenaCOVID-19Cohort StudiesComplement ActivationConvalescenceFemaleHumansImmunization, PassiveMaleMiddle AgedPhagocytosisSARS-CoV-2Young AdultCOVID-19 Serotherapy

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAdultAgedAntibodies, ViralAntibody SpecificityAntibody-Dependent Cell CytotoxicityAntigens, ViralComplement ActivationConvalescenceFemaleHumansImmunization, PassiveMaleMiddle AgedPhagocytosisCohort StudiesBiophysical PhenomenaYoung AdultAntibodies, Neutralizing

Keywords

Convalescent plasmaVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Antibody2019-20 coronavirus outbreakSars virusMedicineImmunologyDiseaseInfectious disease (medical specialty)OutbreakPhagocytosisIgGADCCNeutralizationIGACovid-19Sars-cov-2Functional Antibody ResponseAdultMaleAntibodies, ViralMicrobiologyBiophysical PhenomenaCohort StudiesYoung AdultAntibody SpecificityHumansAntigens, ViralComplement ActivationAgedAntibody-Dependent Cell CytotoxicityImmunization, PassiveConvalescenceMiddle AgedAntibodies, NeutralizingQR1-502FemaleResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being